SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to a recent analyst price target increase, fueling community discussions about its valuation and future potential in the quantum computing sector. Bullish investors are enthusiastic about the momentum, while bears express concerns about the company's fundamentals and potential for a pullback, creating a highly volatile trading environment.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as the community discusses its recent upward momentum and potential for further gains, with some eyeing a squeeze. Bullish investors are eagerly anticipating news and regulatory milestones, while also debating potential government involvement in the sector. Talk centers around technical analysis, short positions, and the long-term prospects of deep-sea mining for critical minerals.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

Galecto (GLTO) is trending amidst high volatility and a low float, drawing comparisons to similar recent runners. The community is actively debating potential price movements, with some anticipating further gains while others foresee a sharp decline, fueled by short squeezes and profit-taking. Speculation is rampant despite the lack of apparent news, contributing to the stock's pump-and-dump chatter.

Siyata Mobile, Inc. engages in the provision of cellular communications systems for enterprise customers. It specializes in connected vehicle products for professional fleets, marketed under the Uniden Cellular and Siyata brands. The firm operates through the following geographical segments: Europe, the Middle East and Africa; Unites States; Canada; and Australia and New Zealand. The company was founded by Marc Seelenfreund on October 15, 1986 and is headquartered in Montreal, Canada.

Core AI Holdings Inc.

Core AI Holdings, Inc.

Core AI Holdings ($CHAI) is trending as the merger with Core Gaming finalizes, with the new ticker set to debut soon, though some users report trading difficulties on certain platforms. The community is weighing the impact of the merger and reverse split, while also speculating on future performance and potential short squeezes. Some are optimistic about the AI gaming sector and the company's revenue, while others voice concerns over platform issues and potential dilution.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin ($APP) is trending due to reports of an SEC probe into its data collection practices, sparking debate among investors. While some view the dip as a buying opportunity, citing Citigroup's recommendation, others express concerns about the potential impact on the company's future. The community is closely watching for further developments and the company's response.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending as retail traders discuss its high valuation and potential for a pullback, while others point to partnerships and government interest as reasons for continued bullishness. Debate centers around whether the stock is experiencing a short squeeze, and if it can sustain its current market capitalization given its revenue. The community is closely watching key price levels and potential impacts from future earnings reports.

Richtech Robotics, Inc. engages in the development of robotic technologies. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics ($RR) is trending as traders discuss a potential short squeeze and the company's upcoming robot release. Community members are debating price targets and whether to hold or sell, with bulls citing strong momentum and potential double-digit gains. The broader conversation includes discussion of the company's fundamentals, potential for dilution, and comparisons to other robotics and AI stocks.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending amid speculation of a partnership with Tesla, sparked by a teaser video and social media buzz. The community is actively discussing potential price targets and the likelihood of a short squeeze, while also considering Archer's broader prospects in the eVTOL market and military applications. Some investors are cautioning about a potential "buy the rumor, sell the news" scenario if the Tesla speculation doesn't materialize.

Trilogy Metals, Inc. engages in the development and exploration of mineral properties. The firm holds interests in the Upper Kobuk mineral projects that include the Arctic, a copper-zinc-lead-gold-silver and Bornite, a carbonate-hosted copper projects, which is located in the Ambler mining district in Northwest Alaska. The company was founded on April 27, 2011 and is headquartered in Vancouver, Canada.

Trilogy Metals Inc

Trilogy Metals ($TMQ) is trending after the U.S. government announced a strategic investment to support mining exploration in Alaska, aiming to secure domestic supplies of critical minerals. The community is actively discussing the potential for a short squeeze and significant price appreciation, though some caution against potential pullbacks or offerings. This development underscores the government's focus on bolstering domestic mineral resources for national security and technological advancement.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum Inc. ($QBTS) is trending amid discussions about a potential short squeeze and overall momentum in the quantum computing sector. Community members are debating the company's valuation and future prospects, with some highlighting its potential in AI and clean technology, while others express concerns about dilution and competition from larger tech companies. There's also speculation about potential partnerships or acquisitions, contributing to the stock's recent volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$LUCD i really don’t care about a guy incessantly decrying a stock because he got killed in the name and now has made it his mission in life to belittle the co. Instead, ask yourself why a director bought over 400k shares at $1.30 (once there and then again another 100k at $1.0). Ask why the latest raise at $1 was oversubscribed. So do you want to take advice from a lunatic who has nothing to do but bash all day or from a director who just so happens to run a large hospital complex in Virginia? Who do you think has more insight into the possibilities?

Frank T

Mike Smith

Kurt

Jeff

Steve G

okay

Judith

Nightwolf6502

Bryan

Michael Casey

KYLE ANDERSON

PavmFollower

StockTwits for iOS

Lucid Diagnostics Inc

 i really don’t care about a guy incessantly decrying a stock because he got killed in the name and now has made it his mission in life to belittle the co. Instead, ask yourself why a director bought over 400k shares at $1.30 (once there and then again another 100k at $1.0). Ask why the latest raise at $1 was oversubscribed. So do you want to take advice from a lunatic who has nothing to do but bash all day or from a director who just so happens to run a large hospital complex in Virginia? Who do you think has more insight into the possibilities?

Edward sherman

@edward103 That Director has LOST money on EVERY insider buy he has EVER MADE.  https://www.sec.gov/edgar/browse/?CIK=0001817012  check it out. 
 
The latest raise was done at a 20+% discount, that is why it was oversubscribed.  All the PUMPERS said $LUCD did not and would not do a financing.  Then they all said it would be at $1.20 or MORE!! 
 
The facts are that LUCD loses $52M per year and burns real cash of $46M.  That despite the latest raise LUCD runs out of money (BROKE) in the Summer of 2026.  That Lishan and Dennis have ALWAYS wanted 6 months funds available as that GUARANTEES the $60K EACH they take out of $PAVM &amp; LUCD EVERY month.   
 
That Dennis the CFO has less than 1 months salary invested in PAVM ($22K) 
 
LUCD will have to raise OVER $100M in Q1 or Q2 2026.  A good raise would be at $1 but I believe it will be MAYBE at $1 but ONLY if it has WARRANTS. 
 
Today there are OVER 230M shares outstanding and if you take CSTL as a realistic peer comparison then LUCD should trade at between 50 cents to 75 cents.   
 
FACTS

EDGAR Entity Landing Page

StockTwits Web

PAVmed Inc

 That Director has LOST money on EVERY insider buy he has EVER MADE.  

  check it out. 
 
The latest raise was done at a 20+% discount, that is why it was oversubscribed.  All the PUMPERS said 

 did not and would not do a financing.  Then they all said it would be at $1.20 or MORE!! 
 
The facts are that LUCD loses $52M per year and burns real cash of $46M.  That despite the latest raise LUCD runs out of money (BROKE) in the Summer of 2026.  That Lishan and Dennis have ALWAYS wanted 6 months funds available as that GUARANTEES the $60K EACH they take out of 

 & LUCD EVERY month.   
 
That Dennis the CFO has less than 1 months salary invested in PAVM ($22K) 
 
LUCD will have to raise OVER $100M in Q1 or Q2 2026.  A good raise would be at $1 but I believe it will be MAYBE at $1 but ONLY if it has WARRANTS. 
 
Today there are OVER 230M shares outstanding and if you take CSTL as a realistic peer comparison then LUCD should trade at between 50 cents to 75 cents.   
 
FACTS

dave

@dmc4321 relax. You obviously have an axe to grind. I was long PAVM before you were toutung it (I’ve seen your posts). I bailed at $5. Getting long LUCD at $1 for me makes all the sense in the world. They did that $25 million raise knowing that medicare coverage is coning abd they can look back 1 year from coverage. Forget what the CEO said in re 1 year look back revenue on the last call. They will use all their resources now to target Medicare recepients knowing reimbursement is coming. If they did 3,500 per Q risking getting paid what will they do knowing payment is forthcoming? Can they get to 7,000? Thats $14MM in quarterly revenue. When the street sees that the stock re-rates. Will it be $8? I doubt it. But it will be $2.50 and fast.

 relax. You obviously have an axe to grind. I was long PAVM before you were toutung it (I’ve seen your posts). I bailed at $5. Getting long LUCD at $1 for me makes all the sense in the world. They did that $25 million raise knowing that medicare coverage is coning abd they can look back 1 year from coverage. Forget what the CEO said in re 1 year look back revenue on the last call. They will use all their resources now to target Medicare recepients knowing reimbursement is coming. If they did 3,500 per Q risking getting paid what will they do knowing payment is forthcoming? Can they get to 7,000? Thats $14MM in quarterly revenue. When the street sees that the stock re-rates. Will it be $8? I doubt it. But it will be $2.50 and fast.

@edward103 @dmc4321 

I doubt you were invested in $PAVM before I was.  I decided not to invest based on someone on Twitter saying that he did not believe that CarpX would get FDA approval first time it applied.  He was right.  I invested after CarpX was resubmitted and approved.  Made money on PAVM and never invested in LUCD.

If you think logically you will see your $2.50 is not going to happen.  $LUCD Must raise another $100m+ in Q1 or Q2 of 2026.  That big a raise will be at $1 or below and probably have warrants.  So with 330M shares outstanding a $2.50 price is a $825M   Market Cap.

Think about it another way.  On average LUCD did 167 covered tests per month in the 1H of 2025.  If you read the Sept 8 CC transcript you start to understand the logistical issues and challenges.  Lishan states that one of their big advocates was considering POSSIBLY doing the EsoGuard test themselves, otherwise their Nurse must continue to travel once a month.

Digest the implications of that.

StockTwits For Android 

 before I was.  I decided not to invest based on someone on Twitter saying that he did not believe that CarpX would get FDA approval first time it applied.  He was right.  I invested after CarpX was resubmitted and approved.  Made money on PAVM and never invested in LUCD.

If you think logically you will see your $2.50 is not going to happen.  

 Must raise another $100m+ in Q1 or Q2 of 2026.  That big a raise will be at $1 or below and probably have warrants.  So with 330M shares outstanding a $2.50 price is a $825M   Market Cap.

Think about it another way.  On average LUCD did 167 covered tests per month in the 1H of 2025.  If you read the Sept 8 CC transcript you start to understand the logistical issues and challenges.  Lishan states that one of their big advocates was considering POSSIBLY doing the EsoGuard test themselves, otherwise their Nurse must continue to travel once a month.

Digest the implications of that.

LPlates

@LPlates @dmc4321 you’re italian, canadian right? I remember going back and forth with you on PAVM. You hot creamed in that.

 you’re italian, canadian right? I remember going back and forth with you on PAVM. You hot creamed in that.

@LPlates @dmc4321 so my italian/canadian friend who took a beating on PAVM and just can’t let it go has now made it his mission to warn all others about LUCD. You have no freaking clue when and what price a subsequent secondary will come and at what price. Hiw fast adoprion comes with Medicare and whether other national payors jump on board, what partnerships they can form, what the market might be doing. Its a fools game to run the numbers the way you you’re doing it. Instead, watch the insiders and I will go with the director of one of the largest private hospitaks in Virginia and a Director on the Board.

 so my italian/canadian friend who took a beating on PAVM and just can’t let it go has now made it his mission to warn all others about LUCD. You have no freaking clue when and what price a subsequent secondary will come and at what price. Hiw fast adoprion comes with Medicare and whether other national payors jump on board, what partnerships they can form, what the market might be doing. Its a fools game to run the numbers the way you you’re doing it. Instead, watch the insiders and I will go with the director of one of the largest private hospitaks in Virginia and a Director on the Board.

@edward103 EXACTLY!!! Mathias makes a good salary at Sentara, but I don&#39;t think he&#39;s splashing a half mill in the pot for the action.

 EXACTLY!!! Mathias makes a good salary at Sentara, but I don't think he's splashing a half mill in the pot for the action.